CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
9.8100
0.46%
Market Trading Hours* (UTC) Open now
Closes on Wednesday at 16:30

Mon - Fri: 08:00 - 16:30

  • Summary
  • Historical Data
Trading сonditions
Spread 0.1200
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023925 %
Charges from full value of position ($-4.55)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023925%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.002007 %
Charges from full value of position ($0.38)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.002007%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency GBP
Margin 5.00%
Stock exchange United Kingdom of Great Britain and Northern Ireland
Commission on trade 0%

Key Stats
Prev. Close 9.89
Open 9.93
1-Year Change -18.81%
Day's Range 9.76 - 9.97
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jan 21, 2025 9.8900 0.1550 1.59% 9.7350 10.0795 9.6900
Jan 20, 2025 9.9150 0.4700 4.98% 9.4450 10.0895 9.4350
Jan 17, 2025 9.4800 0.0000 0.00% 9.4800 9.7500 9.2905
Jan 16, 2025 9.5050 0.1595 1.71% 9.3455 9.5750 9.2155
Jan 15, 2025 9.4005 0.3500 3.87% 9.0505 9.4355 9.0505
Jan 14, 2025 9.1455 -0.1150 -1.24% 9.2605 9.4405 8.9805
Jan 13, 2025 9.3905 -0.1945 -2.03% 9.5850 9.6650 9.1205
Jan 10, 2025 9.6800 0.2450 2.60% 9.4350 9.8100 9.4350
Jan 9, 2025 9.6400 0.0300 0.31% 9.6100 9.8500 9.5950
Jan 8, 2025 9.6950 -0.0250 -0.26% 9.7200 9.9350 9.4100
Jan 7, 2025 9.8200 0.2350 2.45% 9.5850 9.8250 9.2555
Jan 6, 2025 9.8050 -0.1795 -1.80% 9.9845 10.1795 9.6050
Jan 3, 2025 9.8600 -0.0445 -0.45% 9.9045 10.0895 9.6100
Jan 2, 2025 9.7950 -0.2845 -2.82% 10.0795 10.3395 9.7850
Dec 31, 2024 10.2395 0.5645 5.83% 9.6750 10.2595 9.6750
Dec 30, 2024 9.6450 -0.0200 -0.21% 9.6650 9.9100 9.5800
Dec 27, 2024 9.8850 0.3650 3.83% 9.5200 9.9250 9.5200
Dec 24, 2024 9.5900 0.1400 1.48% 9.4500 9.7600 9.3605
Dec 23, 2024 9.4305 0.3950 4.37% 9.0355 9.4805 9.0305
Dec 20, 2024 9.1705 0.2150 2.40% 8.9555 9.2355 8.9060

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Indivior Company profile

About Indivior PLC

Indivior PLC is a United Kingdom-based pharmaceutical company. The Company is engaged in developing medicines to treat addiction and serious mental illnesses. It focuses to build a portfolio of opioid dependence treatments. It has a pipeline of product candidates designed to address other chronic conditions and cooccurring disorders of addiction, including alcohol use disorder. Its product pipeline focuses on development and discovery of non-opioid treatment strategies for opioid use disorder (OUD), as well as new therapies to address the needs of people suffering from alcohol, stimulant and cannabis use disorders. Its pipeline products include INDV-3000 - Selective Dopamine D3-receptor Antagonist, RBP-6000 - Buprenorphine XR injection, Buprenorphine/ Naloxone Sublingual Film, Buprenorphine/ Naloxone Sublingual Tablet and Buprenorphine Sublingual Tablet, among others. Its portfolio of products is available in more than 40 countries.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Indivior PLC revenues increased 22% to $791M. Net income totaled $205M vs. loss of $148M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Other operating income increase from $0K to $32M (income), Selling/General/Admin. Expense, decrease of 5% to $192M (expense).

Industry: Proprietary & Advanced Pharmaceuticals

234 Bath Road
SLOUGH
BERKSHIRE SL1 4EE
GB

People also watch

US100

21,736.00 Price
+0.480% 1D Chg, %
Long position overnight fee -0.0233%
Short position overnight fee 0.0011%
Overnight fee time 22:00 (UTC)
Spread 1.8

Gold

2,761.55 Price
+0.580% 1D Chg, %
Long position overnight fee 0.0110%
Short position overnight fee -0.0193%
Overnight fee time 22:00 (UTC)
Spread 0.30

BTC/USD

104,920.30 Price
-1.880% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

XRP/USD

3.16 Price
-1.040% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01578

Still looking for a broker you can trust?

Join the 680,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading